MedPath

Effect of hormonal therapy versus no treatment on testicular histopathology and fertility in patients with non-obstructive azoospermia

Phase 2
Conditions
non-obstructive azoospermia.
Male infertility
Registration Number
IRCT201612069014N137
Lead Sponsor
Vice-chancellor for Research the Technology, Hamadan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Male
Target Recruitment
28
Inclusion Criteria

Male; non-obstructive azoospermia; normal sexual hormones.
Exclusion criteria: Severe testicular atrophy; varicocele; chromosomal abnormality; sertoli cell syndrome; hypogonadism.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Sperm analysis. Timepoint: 10 weeks after treatment. Method of measurement: through laboratory sampling.;Histopathology of testis. Timepoint: 10 weeks after treatment. Method of measurement: trough biopsy.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath